functional protein microarray platform immunometm (Sengenics Corporation Pte)
90
Structured Review
Sengenics Corporation Pte
functional protein microarray platform immunometm
Functional Protein Microarray Platform Immunometm, supplied by Sengenics Corporation Pte, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/functional+protein+microarray+platform+immunometm/immunometm+protein+array/pm32356904-31-1-9
Average 90 stars, based on 1 article reviews
Functional Protein Microarray Platform Immunometm, supplied by Sengenics Corporation Pte, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/functional+protein+microarray+platform+immunometm/immunometm+protein+array/pm32356904-31-1-9
Average 90 stars, based on 1 article reviews
functional protein microarray platform immunometm - by Bioz Stars,
2026-10
90/100 stars
Images
Related Articles
Functional Assay:Article Title: Identification of novel candidate autoantibodies in Alzheimer's disease. Article Snippet: This article is protected by copyright.. All rights reserved Background and purpose: Accumulated failures in Alzheimer’s disease (AD) clinical trials have highlighted an urgent need to identify additional biomarkers involved in AD.. Recently, mounting evidence reported that autoantibodies are ubiquitous in human sera. Microarray:Article Title: Identification of novel candidate autoantibodies in Alzheimer's disease. Article Snippet: This article is protected by copyright.. All rights reserved Background and purpose: Accumulated failures in Alzheimer’s disease (AD) clinical trials have highlighted an urgent need to identify additional biomarkers involved in AD.. Recently, mounting evidence reported that autoantibodies are ubiquitous in human sera. Immunopeptidomics:Article Title: Identification of novel candidate autoantibodies in Alzheimer's disease. Article Snippet: This article is protected by copyright.. All rights reserved Background and purpose: Accumulated failures in Alzheimer’s disease (AD) clinical trials have highlighted an urgent need to identify additional biomarkers involved in AD.. Recently, mounting evidence reported that autoantibodies are ubiquitous in human sera. |